- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- March 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- January 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- January 2025
- 178 Pages
Global
From €2633EUR$3,000USD£2,278GBP
- Report
- July 2025
- 287 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 402 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 385 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 396 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 596 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 376 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 385 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 405 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 383 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 389 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 467 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 278 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 209 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 284 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 170 Pages
Global
From €5134EUR$5,850USD£4,442GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more